How can we help?

Pricing strategies that reflect the true value of your asset and insights to help you understand and quantify investment trade-offs.

Optimal global
pricing strategies

Expert support in crafting a coherent global pricing strategy that anticipates payer and stakeholder views of the perceived value of your asset.

Expert support in crafting a coherent global pricing strategy that anticipates payer and stakeholder views of the perceived value of your asset.

Quantification of
investment trade-offs

Current insight helps you understand and quantify investment trade-offs related to trial design, the reimbursable population, evidence generation, and achievable price.

Current insight helps you understand and quantify investment trade-offs related to trial design, the reimbursable population, evidence generation, and achievable price.

Agile strategy
frameworks

Pricing and reimbursement assessments uncover market issues that drive decision-making and inform a strategy framework that adapts with your developing asset and the evolving landscape.

Pricing and reimbursement assessments uncover market issues that drive decision-making and inform a strategy framework that adapts with your developing asset and the evolving landscape.

Critical landscape
analysis

Comprehensive assessment of the pricing and reimbursement landscape through critical analysis of existing health technology assessment and reimbursement decisions.

Comprehensive assessment of the pricing and reimbursement landscape through critical analysis of existing health technology assessment and reimbursement decisions.

Test willingness
to pay

Tailored research based on different endpoint scenarios improves understanding of payer evidence requirements and supports your value-based pricing and reimbursement strategy.

Tailored research based on different endpoint scenarios improves understanding of payer evidence requirements and supports your value-based pricing and reimbursement strategy.

Explore payer and clinician decision-drivers

Primary research through international advisory boards and interviews with payers and clinicians to understand real-world issues and decision-drivers, and how these support pricing negotiations.

Primary research through international advisory boards and interviews with payers and clinicians to understand real-world issues and decision-drivers, and how these support pricing negotiations.

Thanks for making the information practical and insightful. I think the overall response from the commercial and broader teams was very positive and the content will be incredibly helpful for our strategy.

Senior Manager, Oncology Global Market Access and Pricing, top-20 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.

We would be delighted to have a confidential conversation about your market access needs.